COMMUNIQUÉ DE PRESSE publié le 13/09/2023 à 14:30, il y a 2 années 6 mois Patent Issued in Japan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
COMMUNIQUÉ DE PRESSE publié le 12/09/2023 à 14:30, il y a 2 années 6 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
COMMUNIQUÉ DE PRESSE publié le 11/09/2023 à 14:30, il y a 2 années 6 mois Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference
COMMUNIQUÉ DE PRESSE publié le 07/09/2023 à 14:30, il y a 2 années 6 mois Jaguar Health's Executive VP Dr. Karen Brunke Joins BIO's Rare Disease and Orphan Drugs Committee
COMMUNIQUÉ DE PRESSE publié le 30/08/2023 à 14:30, il y a 2 années 6 mois The Science Times Publishes Article About Jaguar Health's Focus on Developing Crofelemer for Two Rare Disease Indications
COMMUNIQUÉ DE PRESSE publié le 28/08/2023 à 14:30, il y a 2 années 6 mois Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference
COMMUNIQUÉ DE PRESSE publié le 24/08/2023 à 13:00, il y a 2 années 7 mois Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
COMMUNIQUÉ DE PRESSE publié le 17/08/2023 à 14:30, il y a 2 années 7 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
COMMUNIQUÉ DE PRESSE publié le 16/08/2023 à 14:30, il y a 2 années 7 mois Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
COMMUNIQUÉ DE PRESSE publié le 14/08/2023 à 14:00, il y a 2 années 7 mois Jaguar Health Reports Second Quarter 2023 Financial Results
Publié le 24/03/2026 à 17:46, il y a 11 heures 22 minutes NRJ GROUP - Press release annual results 2025
Publié le 25/03/2026 à 04:50, il y a 18 minutes Arctic Fox Announces Closing of First Tranche of Non-Brokered Private Placement
Publié le 24/03/2026 à 23:00, il y a 6 heures 8 minutes Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Publié le 24/03/2026 à 18:55, il y a 10 heures 13 minutes Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Publié le 24/03/2026 à 13:30, il y a 15 heures 38 minutes GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Publié le 24/03/2026 à 21:08, il y a 8 heures Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Publié le 24/03/2026 à 19:49, il y a 9 heures 19 minutes EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Publié le 24/03/2026 à 19:41, il y a 9 heures 26 minutes ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Publié le 24/03/2026 à 19:05, il y a 10 heures 3 minutes WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Publié le 24/03/2026 à 18:39, il y a 10 heures 28 minutes EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
